The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice

Journal of Medical Virology

Volumn 79, Issue 9, 2007, Pages 1334-1342

  Schmidtke, M ^a,c   Merkle, I ^a   Klingel, K ^b   Hammerschmidt, E ^a   Zautner, A E ^a   Wutzler, P ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Capsid proteins; Coxsackievirus B3 induced myocarditis; Pancreatitis; Persistence; Picornavirus; Tropism

Indexed keywords

COMPLEMENTARY DNA; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 1; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B3; DISEASE COURSE; HEART; HEART DISEASE; HEART MUSCLE INJURY; HISTOPATHOLOGY; MALE; MOUSE; MYOCARDITIS; NONHUMAN; OUTBRED STRAIN; PANCREAS; TREATMENT OUTCOME; VIRAL GENETICS; VIRUS LOAD;

ANIMALS; ANTIBODIES, VIRAL; COXSACKIEVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; ENTEROVIRUS B, HUMAN; HEART; MALE; MICE; MYOCARDITIS; MYOCARDIUM; PANCREAS; RNA, VIRAL; SPLEEN; VIRAL LOAD;

COXSACKIEVIRUS; MIRIDAE; MUS; PICORNAVIRIDAE;

EID: 34547100279     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20933     Document Type: Article

References (32)

1. Anderson DR, Wilson JE, Carthy CM, Yang D, Kandolf R, McManus BM. 1996. Direct interactions of coxsackievirus B3 with immune cells in the splenic compartment of mice susceptible or resistant to myocarditis. J Virol 70:4632-4645.
2. Bear JS, Byrnes AP, Griffin DE. 2006. Heparin-binding and patterns of virulence for two recombinant strains of Sindbis virus. Virology 347:183-190.
3. Beck MA, Chapman NM, McManus BM, Mullican JC, Tracy S. 1990. Secondary enterovirus infection in the murine model of myocarditis. Pathologic and immunologic aspects. Am J Pathol 136:669-681.
4. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
5. Chow LH, Gauntt CJ, McManus BM. 1991. Differential effects of myocarditic variants of Coxsackievirus B3 in inbred mice. A pathologic characterization of heart tissue damage. Lab Invest 64:55-64.
6. Dunn JJ, Chapman NM, Tracy S, Romero JR. 2000. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: Localization to the 5′ nontranslated region. J Virol 74:4787-4794.
7. Dunn JJ, Bradrick SS, Chapman NM, Tracy SM, Romero JR. 2003. The stem loop II within the 5′ nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model. J Infect Dis 187:1552-1561.
8. Gatmaitan BG, Chason JL, Lerner AM. 1970. Augmentation of the virulence of murine coxsackie-virus B-3 myocardiopathy by exercise. J Exp Med 131:1121-1136.
9. Gauntt CJ, Gomez PT, Duffey PS, Grant JA, Trent DW, Witherspoon SM, Paque RE. 1984. Characterization and myocarditic capabilities of coxsackievirus B3 variants in selected mouse strains. J Virol 52:598-605.
10. Gluck B, Schmidtke M, Merkle I, Stelzner A, Gemsa D. 2001. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice. J Mol Cell Cardiol 33:1615-1626.
11. Gomez RM, Cui X, Castagnino CG, Berria MI. 1993. Differential behaviour in pancreas and heart of two coxsackievirus B3 variants. Intervirology 36:153-160.
12. Grumbach IM, Heim A, Pring-Akerblom P, Vonhof S, Hein WJ, Muller G, Figulla HR. 1999. Adenoviruses and enteroviruses as pathogens in myocarditis and dilated cardiomyopathy. Acta Cardiol 54:83-88.
13. He Y, Chipman PR, Howitt J, Bator CM, Whitt MA, Baker TS, Kuhn RJ, Anderson CW, Freimuth P, Rossmann MG. 2001. Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor. Nat Struct Biol 8:874-878.
14. Huber SA. 1997. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice. Lab Invest 76:691-701.
15. Klingel K, Kandolf R. 1993. The role of enterovirus replication in the development of acute and chronic heart muscle disease in different immunocompetent mouse strains. Scand J Infect Dis Suppl 88:79-85.
16. Klingel K, Hohenadl C, Canu A, Albrecht M, Seemann M, Mall G, Kandolf R. 1992. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: Quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci USA 89:314-318.
17. Klingel K, McManus BM, Kandolf R. 1995. Enterovirus-infected immune cells of spleen and lymph nodes in the murine model of chronic myocarditis: A role in pathogenesis? Eur Heart J 16:42-45.
18. Klingel K, Stephan S, Sauter M, Zell R, McManus BM, Bultmann B, Kandolf R. 1996. Pathogenesis of murine enterovirus myocarditis: Virus dissemination and immune cell targets. J Virol 70:8888-8895.
19. Knowlton KU, Jeon ES, Berkley N, Wessely R, Huber S. 1996. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J Virol 70:7811-7818.
20. Lindberg AM, Crowell RL, Zell R, Kandolf R, Pettersson U. 1992. Mapping of the RD phenotype of the Nancy strain of coxsackievirus B3. Virus Res 24:187-196.
21. Luppi P, Rudert WA, Zanone MM, Stassi G, Trucco G, Finegold D, Boyle GJ, Del Nido P, McGowan FX, Jr., Trucco M. 1998. Idiopathic dilated cardiomyopathy: A superantigen-driven autoimmune disease. Circulation 98:777-785.
22. Merkle I, Tonew M, Gluck B, Schmidtke M, Egerer R, Stelzner A. 1999. Coxsackievirus B3-induced chronic myocarditis in outbred NMRI mice. J Hum Virol 2:369-379.
23. Schmidtke M, Gluck B, Merkle I, Hofmann P, Stelzner A, Gemsa D. 2000a. Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis. J Med Virol 61:518-526.
24. Schmidtke M, Selinka HC, Heim A, Jahn B, Tonew M, Kandolf R, Stelzner A, Zell R. 2000b. Attachment of coxsackievirus B3 variants to various cell lines: Mapping of phenotypic differences to capsid protein VP1. Virology 275:77-88.
25. Selinka HC, Wolde A, Pasch A, Klingel K, Schnorr JJ, Kupper JH, Lindberg AM, Kandolf R. 2002. Comparative analysis of two coxsackievirus B3 strains: Putative influence of virus-receptor interactions on pathogenesis. J Med Virol 67:224-233.
26. Selinka HC, Wolde A, Sauter M, Kandolf R, Klingel K. 2004. Virus-receptor interactions of coxsackie B viruses and their putative influence on cardiotropism. Med Microbiol Immunol (Berl) 193:127-131.
27. Stadnick E, Dan M, Sadeghi A, Chantler JK. 2004. Attenuating mutations in coxsackievirus B3 map to a conformational epitope that comprises the puff region of VP2 and the knob of VP3. J Virol 78:13987-14002.
28. Tonew M, Wagner B, Wagner M, Schmidtke M, Stelzner A. 1996. Permissiveness of human embryonal fibroblasts for coxsackieviruses B3.Investigations on virus genetic markers in vitro and localization of virus receptor distribution by immunogold replica technique. Zentralbl Bakteriol 284:443-456.
29. Tracy S, Hofling K, Pirruccello S, Lane PH, Reyna SM, Gauntt CJ. 2000. Group B coxsackievirus myocarditis and pancreatitis: Connection between viral virulence phenotypes in mice. J Med Virol 62:70-81.
30. Van Houten N, Bouchard PE, Moraska A, Huber SA. 1991. Selection of an attenuated Coxsackievirus B3 variant, using a monoclonal antibody reactive to myocyte antigen. J Virol 65: 1286-1290.
31. Verstrepen WA, Kuhn S, Kockx MM, Van De Vyvere ME, Mertens AH. 2001. Rapid detection of enterovirus RNA in cerebrospinal fluid specimens with a novel single-tube real-time reverse transcription-PCR assay. J Clin Microbiol 39:4093-4096.
32. Zautner AE, Korner U, Henke A, Badorff C, Schmidtke M. 2003. Heparan sulfates and coxsackievirus-adenovirus receptor: Each one mediates coxsackievirus B3 PD infection. J Virol 77:10071-10077.